Related Experiment Video
Updated: Feb 18, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Maternal Outcomes and Resource Utilization in Pregnancy-Related Hospitalizations Among Patients With Irritable Bowel
Muhammad Haris Latif1, Ayesha Kang1, Emaan Mazhar2
1Internal Medicine, SSM Health St. Mary's Hospital, St. Louis, USA.
None:
Background Irritable bowel syndrome (IBS) is common among women of reproductive age, yet its implications for pregnancy-related hospitalizations and maternal outcomes in contemporary inpatient settings remain incompletely characterized. Accordingly, this study aimed to address this gap. Methods We performed a retrospective, cross-sectional analysis of delivery-related hospitalizations from 2020 to 2022 using the Nationwide Inpatient Sample (NIS). IBS was identified using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes documented during the delivery hospitalization. Survey-weighted analyses were used to generate nationally representative estimates. Multivariable regression models, adjusted for demographic factors, obstetric characteristics, medical comorbidities, psychiatric conditions, and substance use, were used to evaluate the associations between IBS and maternal outcomes, length of stay, and total hospital charges. Sensitivity analyses examined placenta-specific outcomes and postpartum infections using more granular outcome definitions. Results Among 2,086,607 weighted pregnancy-related hospitalizations, 4,889 (0.23%) had a documented diagnosis of IBS. Patients with IBS were older and had a higher burden of psychiatric, metabolic, and substance-related comorbidities. After multivariable adjustment, IBS was independently associated with prolonged length of stay (adjusted odds ratio (aOR): 1.29, 95% confidence interval (CI): 1.13-1.48), higher hospital charges (adjusted mean increase: $1,656, 95% CI: $769-$2,544), placental complications (aOR: 1.23, 95% CI: 1.08-1.40), and postpartum infection (aOR: 1.41, 95% CI: 1.00-1.98). IBS was not associated with major maternal complications or mortality. Sensitivity analyses demonstrated outcome specificity. Conclusions In this contemporary nationwide inpatient analysis, IBS was infrequently documented during pregnancy-related hospitalizations but was associated with an increased comorbidity burden, resource utilization, and select obstetric complications. These findings suggest that IBS in pregnancy functions as a marker of obstetric complexity rather than a strong independent risk factor for most major maternal complications.
More Related Videos
05:46Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...